{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:43:06Z","timestamp":1771929786972,"version":"3.50.1"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/crd.0b013e3181d74582","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T10:48:02Z","timestamp":1276166882000},"page":"198-203","source":"Crossref","is-referenced-by-count":19,"title":["The Antiplatelet Effects of Nitrates"],"prefix":"10.1097","volume":"18","author":[{"given":"Rui-Hai","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.ATV.16.1.51","article-title":"Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors.","volume":"16","author":"Langford","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0002-9149(81)90065-5","article-title":"Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo.","volume":"48","author":"Smitherman","year":"1981","journal-title":"Am J Cardiol"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease.","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0038-1649702","article-title":"\u201cSpontaneous\u201d platelet aggregation in whole blood in diabetic and non diabetic survivors of acute myocardial infarction.","volume":"70","author":"Gray","year":"1993","journal-title":"Thromb Haemost"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00019501-199404000-00010","article-title":"The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group.","volume":"5","author":"Becker","year":"1994","journal-title":"Coron Artery Dis"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","article-title":"Platelet hyperreactivity and prognosis in survivors of myocardial infarction.","volume":"322","author":"Trip","year":"1990","journal-title":"N Engl J Med"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.98.15.1481","article-title":"Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes.","volume":"98","author":"Freedman","year":"1998","journal-title":"Circulation"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy.","volume":"47","author":"Fuster","year":"1981","journal-title":"Am J Cardiol"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-0038-1657888","article-title":"Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy.","volume":"54","author":"Kyrle","year":"1985","journal-title":"Thromb Haemost"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/pgmj.72.854.731","article-title":"Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.","volume":"72","author":"Lip","year":"1996","journal-title":"Postgrad Med J"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM199701233360403","article-title":"Ventricular dysfunction and the risk of stroke after myocardial infarction.","volume":"336","author":"Loh","year":"1997","journal-title":"N Engl J Med"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","article-title":"Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.","volume":"29","author":"Dries","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/CIRCULATIONAHA.106.661397","article-title":"Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).","volume":"115","author":"Freudenberger","year":"2007","journal-title":"Circulation"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.CIR.64.6.1089","article-title":"The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.","volume":"64","author":"Brown","year":"1981","journal-title":"Circulation"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-8703(82)90527-0","article-title":"Randomized double-blind comparison of nifedipine and isosorbide dinitrate therapy in variant angina pectoris due to coronary artery spasm.","volume":"103","author":"Ginsburg","year":"1982","journal-title":"Am Heart J"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1161\/01.CIR.94.11.2871","article-title":"Preserved vasodilatory response to nitroglycerin in saphenous vein bypass grafts.","volume":"94","author":"Berglund","year":"1996","journal-title":"Circulation"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI107479","article-title":"The effects of nitroglycerin on coronary collaterals and myocardial contractility.","volume":"52","author":"Cohen","year":"1973","journal-title":"J Clin Invest"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI108040","article-title":"Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog.","volume":"55","author":"Bache","year":"1975","journal-title":"J Clin Invest"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/cvr\/1.2.101","article-title":"Platelet behaviour and drugs used in cardiovascular disease.","volume":"1","author":"Hampton","year":"1967","journal-title":"Cardiovasc Res"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/clc.4960231110","article-title":"Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction.","volume":"23","author":"Gebalska","year":"2000","journal-title":"Clin Cardiol"},{"key":"R21-5-20210203","first-page":"97","article-title":"Effects of isosobide dinitrate on platelet aggregation in vitro and in vivo in patients with coronary artery disease.","volume":"11","author":"Zhou","year":"1995","journal-title":"Chin J Clin Cardiol"},{"key":"R22-5-20210203","first-page":"32","article-title":"Effects of sodium nitroprusside on platelet aggregation in patients with congestive heart failure.","volume":"10","author":"Zhou","year":"1998","journal-title":"Chin Crit Care Med"},{"key":"R23-5-20210203","first-page":"10","article-title":"Effects of sodium nitroprusside on platelet aggregation in patients undergoing heart valve replacement.","volume":"14","author":"Zhou","year":"1998","journal-title":"Chin J Thorac Cardiovasc Surg"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0002-9149(94)90283-6","article-title":"Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris.","volume":"73","author":"Lacoste","year":"1994","journal-title":"Am J Cardiol"},{"key":"R25-5-20210203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0002-9149(90)91130-X","article-title":"Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.","volume":"66","author":"Diodati","year":"1990","journal-title":"Am J Cardiol"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2796.1998.00253.x","article-title":"Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study.","volume":"243","author":"Karlberg","year":"1998","journal-title":"J Intern Med"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0002-9149(92)90563-E","article-title":"Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects.","volume":"70","author":"Chirkov","year":"1992","journal-title":"Am J Cardiol"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00005344-199303000-00006","article-title":"Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris.","volume":"21","author":"Chirkov","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/0002-9149(92)90590-U","article-title":"Antiplatelet and antithrombotic effects of organic nitrates.","volume":"70","author":"Loscalzo","year":"1992","journal-title":"Am J Cardiol"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.CIR.78.3.712","article-title":"Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.","volume":"78","author":"Lam","year":"1988","journal-title":"Circulation"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0038-1650532","article-title":"Effects of NO-donors on thrombus formation and microcirculation in cerebral vessels of the rat.","volume":"76","author":"Sasaki","year":"1996","journal-title":"Thromb Haemost"},{"key":"R32-5-20210203","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.CIR.92.4.1005","article-title":"Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis.","volume":"92","author":"Yao","year":"1995","journal-title":"Circulation"},{"key":"R33-5-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0735-1097(93)90745-M","article-title":"Methylene blue inhibits the antithrombotic effect of nitroglycerin.","volume":"21","author":"Johnstone","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R34-5-20210203","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.CIR.83.6.2122","article-title":"Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries.","volume":"83","author":"Folts","year":"1991","journal-title":"Circulation"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(91)90331-J","article-title":"Oral administration of isosorbide dinitrate inhibits arterial thrombosis in rats.","volume":"201","author":"Plotkine","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"R36-5-20210203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0002-8703(94)90538-X","article-title":"Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis.","volume":"127","author":"Werns","year":"1994","journal-title":"Am Heart J"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00005344-199310000-00017","article-title":"Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.","volume":"22","author":"Rovin","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R38-5-20210203","first-page":"739","article-title":"Cardiovascular Pharmacotherapeutics.","author":"Helisch","year":"1997"},{"key":"R39-5-20210203","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1073\/pnas.122225199","article-title":"Identification of the enzymatic mechanism of nitroglycerin bioactivation.","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"12159","DOI":"10.1073\/pnas.0503723102","article-title":"An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation.","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-5-20210203","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tcm.2006.05.001","article-title":"Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase.","volume":"16","author":"Chen","year":"2006","journal-title":"Trends Cardiovasc Med"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00286702","article-title":"Inheritance of mitochondrial aldehyde dehydrogenase: genotyping in Chinese, Japanese and South Korean families reveals dominance of the mutant allele.","volume":"83","author":"Singh","year":"1989","journal-title":"Hum Genet"},{"key":"R43-5-20210203","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI26564","article-title":"Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin.","volume":"116","author":"Li","year":"2006","journal-title":"J Clin Invest"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/01.ATV.0000179599.71086.89","article-title":"Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans.","volume":"25","author":"Mackenzie","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R45-5-20210203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.bjp.0707116","article-title":"Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2\u2212\/\u2212 mice.","volume":"150","author":"Wenzel","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000264509.36234.51","article-title":"Clinical aspects of platelet inhibitors and thrombus formation.","volume":"100","author":"Meadows","year":"2007","journal-title":"Circ Res"},{"key":"R47-5-20210203","first-page":"259","article-title":"Cardiovascular Pharmacotherapeutics. 2nd ed.","author":"Frishman","year":"2003"},{"key":"R48-5-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI112024","article-title":"N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin.","volume":"76","author":"Loscalzo","year":"1985","journal-title":"J Clin Invest"},{"key":"R49-5-20210203","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1161\/CIRCULATIONAHA.106.675991","article-title":"Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.","volume":"115","author":"Maree","year":"2007","journal-title":"Circulation"},{"key":"R50-5-20210203","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.106.667584","article-title":"Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.","volume":"115","author":"Faraday","year":"2007","journal-title":"Circulation"},{"key":"R51-5-20210203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.crd.0000188033.11188.8e","article-title":"Variability of response to clopidogrel: possible mechanisms and clinical implications.","volume":"14","author":"Nguyen","year":"2006","journal-title":"Cardiol Rev"},{"key":"R52-5-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.crd.0000148175.60718.69","article-title":"Aspirin resistance: mechanisms and clinical implications.","volume":"14","author":"Hanjis","year":"2006","journal-title":"Cardiol Rev"},{"key":"R53-5-20210203","first-page":"G1313","article-title":"Nitric Oxide. V. Therapeutic potential of nitric oxide donors and inhibitors.","volume":"276","author":"Muscara","year":"1999","journal-title":"Am J Physiol"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/13543784.14.11.1347","article-title":"Nitric oxide-modulating agents for gastrointestinal disorders.","volume":"14","author":"Whittle","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"R55-5-20210203","first-page":"305","article-title":"Recent developments in nitric oxide donor drugs.","volume":"151","author":"Miller","year":"2007","journal-title":""},{"key":"R56-5-20210203","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(88)91906-X","article-title":"Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.","volume":"1","author":"Yusuf","year":"1988","journal-title":"Lancet"},{"key":"R57-5-20210203","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJM198205133061901","article-title":"Effect of sodium nitroprusside on mortality in acute myocardial infarction.","volume":"306","author":"Durrer","year":"1982","journal-title":"N Engl J Med"},{"key":"R58-5-20210203","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198205133061902","article-title":"Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study.","volume":"306","author":"Cohn","year":"1982","journal-title":"N Engl J Med"},{"key":"R59-5-20210203","first-page":"1115","article-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction.","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R60-5-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R61-5-20210203","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/01.CIR.97.20.2017","article-title":"Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial.","volume":"97","author":"Mahmarian","year":"1998","journal-title":"Circulation"},{"key":"R62-5-20210203","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/clc.4960240908","article-title":"Continuous long-term dosing with oral slow-release isosorbide dinitrate does not reduce incidence of cardiac events in patients with healed myocardial infarction.","volume":"24","author":"Kanamasa","year":"2001","journal-title":"Clin Cardiol"},{"key":"R63-5-20210203","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1253\/jcj.60.779","article-title":"Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.","volume":"60","author":"Ishikawa","year":"1996","journal-title":"Jpn Circ J"},{"key":"R64-5-20210203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2169\/internalmedicine.39.1020","article-title":"Intermittent nitrate therapy for prior myocardial infraction does not induce rebound angina nor reduce cardiac events.","volume":"39","author":"Ishikawa","year":"2000","journal-title":"Intern Med"},{"key":"R65-5-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(99)70163-8","article-title":"Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group.","volume":"138","author":"Nakamura","year":"1999","journal-title":"Am Heart J"},{"key":"R66-5-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance.","volume":"97","author":"Munzel","year":"2005","journal-title":"Circ Res"},{"key":"R67-5-20210203","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacc.2006.10.074","article-title":"Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism.","volume":"49","author":"Thomas","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R68-5-20210203","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/hc1002.105186","article-title":"Functional and biochemical analysis of endothelial (Dys)function and NO\/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.","volume":"105","author":"Schulz","year":"2002","journal-title":"Circulation"},{"key":"R69-5-20210203","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/ATVBAHA.107.148023","article-title":"Combating nitrate tolerance: a novel endogenous mechanism.","volume":"27","author":"Gutterman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R70-5-20210203","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM198709243171304","article-title":"Prevention and reversal of nitrate tolerance in patients with congestive heart failure.","volume":"317","author":"Packer","year":"1987","journal-title":"N Engl J Med"},{"key":"R71-5-20210203","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.96.8.2545","article-title":"Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance.","volume":"96","author":"Watanabe","year":"1997","journal-title":"Circulation"},{"key":"R72-5-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.fjc.0000167010.98177.78","article-title":"Rosuvastatin treatment protects against nitrate-induced oxidative stress.","volume":"46","author":"Otto","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R73-5-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0167-5273(02)00529-6","article-title":"Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia.","volume":"90","author":"Inoue","year":"2003","journal-title":"Int J Cardiol"},{"key":"R74-5-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00005344-200302000-00006","article-title":"Effect of folic acid on nitrate tolerance in healthy volunteers: differences between arterial and venous circulation.","volume":"41","author":"Gori","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R75-5-20210203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00005344-199303000-00019","article-title":"Interaction between hydralazine and nitrovasodilators in vascular smooth muscle.","volume":"21","author":"Unger","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"R76-5-20210203","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1172\/JCI118935","article-title":"Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.","volume":"98","author":"Munzel","year":"1996","journal-title":"J Clin Invest"},{"key":"R77-5-20210203","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0735-1097(95)00368-1","article-title":"Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.","volume":"26","author":"Gogia","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R78-5-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.CIR.84.1.35","article-title":"Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.","volume":"84","author":"Bauer","year":"1991","journal-title":"Circulation"},{"key":"R79-5-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.","volume":"5","author":"Carson","year":"1999","journal-title":"J Card Fail"},{"key":"R80-5-20210203","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"R81-5-20210203","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.106.644013","article-title":"Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate\/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"key":"R82-5-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2261-6-44","article-title":"Mitochondrial oxidative stress and nitrate tolerance\u2014-comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+\/\u2212 mice.","volume":"6","author":"Mollnau","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"R83-5-20210203","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1538-7836.2005.01605.x","article-title":"A novel nitric oxide-releasing statin derivative exerts an antiplatelet\/antithrombotic activity and inhibits tissue factor expression.","volume":"3","author":"Rossiello","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R84-5-20210203","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1538-7836.2007.02543.x","article-title":"A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects.","volume":"5","author":"Zafar","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R85-5-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cardiores.2003.11.034","article-title":"Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.","volume":"61","author":"Vilahur","year":"2004","journal-title":"Cardiovasc Res"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00045415-201007000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:56:55Z","timestamp":1618034215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201007000-00005"}},"subtitle":["Is it of Clinical Significance in Patients With Cardiovascular Disease?"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e3181d74582","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}